Chamoun George

CEO George Chamoun bought 24,272 shares of ACVA at $5.05 as stock down 70.7% from 52-week high

Chamoun purchased 24,272 shares at $5.05 on 2026-03-09, adding to his position of 2.95M shares in a company trading -70.7% from its 52-week high of $17.04. His recent buying pattern at ACVA shows mixed outcomes: his two prior buys at this ticker (2026-02-09 and 2026-01-12) both declined significantly 30 days after purchase (-31.5% and -18.3% respectively), though an earlier December 2025 buy posted a +10.9% 30-day return. His cross-ticker track record shows only 3 prior buys with an average 30-day return of -13.0%, suggesting open-market purchases have historically underperformed. ACVA remains unprofitable with negative $-24.5M net income in the latest quarter, and the stock has declined -31.5% over the past 30 days and -38.3% over 90 days, providing context for the severely depressed entry price relative to recent trading range.

CEO George Chamoun buys 16,892 shares of ACVA at $7.30 amid -66.2% decline from 52-week high.

Chamoun purchased 16,892 shares at $7.30 on 2026-02-09, bringing his total holdings to 2,928,705 shares. This marks his second consecutive buy at ACVA within two months—he purchased shares again on 2026-01-12 and prior on 2025-12-15. The current price of $7.29 sits -66.2% from the 52-week high of $21.60 and reflects a 30-day decline of -17.0%, though the stock is up +32.8% over 90 days. At the same-ticker level, his prior buy on 2025-12-15 delivered a 30-day return of +10.9%, and two of his three prior ACVA trades proved well-timed at the 90-day mark. The company remains unprofitable (net income of $-24,465,000.00 for the latest quarter) but is growing revenue at +32.4% annually. Consecutive purchases during a sharp recent decline, combined with historical accuracy on this specific stock, warrant monitoring for conviction signals, though the steep valuation discount and near-term price volatility merit deeper scrutiny into the company's path to profitability.

CEO Chamoun George bought 14,286 shares of ACVA at $8.81 on 2026-01-12; stock now $8.74, -60.7% from 52-week high.

Chamoun George, Chief Executive Officer of ACV Auctions Inc., purchased 14,286 shares at $8.81 on 2026-01-12, increasing his holdings to 2,598,383 shares. The purchase occurs at a price 60.7% below the 52-week high of $22.25, and the stock is currently trading at $8.74, just $0.07 below the transaction price. At the same ticker, George has a mixed record: 2 of 4 prior measurable trades (both sales) were well-timed at the 90-day mark, with significant declines following two June 2025 sales (-35.1% and -33.0% respectively), but earlier March 2025 sales showed minimal 90-day movement. His cross-ticker track record shows 1 prior buy against 19 prior sells with a 47.37% well-timed rate—a below-average 90-day timing record. The company reported $199.6M in quarterly revenue with +32.4% annual growth, but posted a net loss of $24.5M, indicating continued unprofitability despite top-line expansion.

ACVA CEO Chamoun George purchased 31,172 shares at $7.97 on 2025-12-15 (total value $248,440.84); currently trading -65.3% from 52-week high at $7.72.

Chamoun George, CEO of ACV Auctions Inc., executed a $248.4K open-market share purchase at $7.97 on 2025-12-15, adding 31,172 shares to his holdings (now 2,618,714 shares total). The stock is currently trading at $7.72, down 65.3% from its 52-week high of $22.25, and the company remains unprofitable with a reported net loss of $-24,465,000.00 despite generating $199,561,000.00 in quarterly revenue (+32.4% annual growth). The timing is notable: his prior five trades at ACVA were all sells, with three of five demonstrating favorable 90-day outcomes (stock fell post-sale), suggesting a pattern of selling into strength. This buy occurs after significant price deterioration and follows a 30-day rebound of +22.5%, creating context for interpreting whether this represents opportunistic accumulation or a shift in the insider's recent selling posture at this ticker.

CEO Chamoun George sold 350,000 shares (350.0K shares) at $16.81 avg for $5.9M on June 10-11, reducing stake by 11.6%

Chamoun George executed 2 separate sales totaling 350,000 shares for $5,882,560.18, reducing his holdings from 3,004,367 to 2,654,367 shares post-transaction. The company is currently unprofitable with net income of $-14,817,000.00 against quarterly revenue of $182,697,000.00, despite strong annual revenue growth of +32.4%. The stock has declined 29.1% from its 52-week high of $23.17 to the current price of $16.42, though it is up 14.7% over 90 days. His prior ACVA sales show a 2-of-3 well-timed rate at the 90-day mark, with the December 2024 sales preceding declines of -36.4% and -39.5%, suggesting he has historically exited ahead of material price weakness at this ticker.

CEO Chamoun George sells 350,000 ACVA shares in 2 tranches for $5.4M; stock down 33.9% from 52-week high, company unprofitable.

Chamoun George, as CEO, executed 2 separate sales totaling 350,000 shares (350.0K shares) for $5,368,404.66 ($5.4M) at blended average price of $15.34 on 2025-03-19 and 2025-03-20, reducing his holdings from 3,171,193 shares (3.17M shares) to 2,821,193 shares (2.82M shares), a -11.0% reduction in his position. The sales occur as the stock trades at $15.31 current price, representing -33.9% from the 52-week high and -25.9% over the prior 30 days. ACV Auctions reported revenue of $171,329,000.00 ($171.3M) in its latest quarter but carries negative net income of $-16,029,000.00 ($-16.0M), with the company remaining unprofitable on a full-year basis despite +32.4% annual revenue growth. The CEO's prior 5 trades at ACVA show 2 of 5 were well-timed at the 90-day mark, with December 2024 sales posting 90-day declines of -36.4% and -39.5%, but the June 2024 and September 2024 sales posted 90-day gains of +16.7%, +4.7%, and +3.5%, indicating mixed timing outcomes at this ticker.

CEO George Chamoun sold 350,000 shares at $21.65 avg over 2 trades; now holds 872.4K shares, down 28.6% from prior level.

CEO George Chamoun executed two separate sales on consecutive days totaling 350,000 shares (350.0K shares) for $7,576,792.00 at a blended average price of $21.65, reducing his holdings by 28.6% to 872.4K shares. The sale was priced near the 52-week high of $23.17, with the stock currently at $20.94. His prior sales at ACVA show a mixed record: three measurable 90-day outcomes (June trades) all posted positive returns of 12.6%–16.7%, meaning the stock rose after he sold; his most recent two September sales posted 30-day losses of -5.3% and -6.5%, though 90-day outcomes are not yet measurable. The company remains unprofitable with net income of $-16.0M on revenue of $171.3M, despite positive annual revenue growth of 14.2%. The substantial share reduction warrants attention to whether this reflects capital reallocation or shifts in insider confidence regarding near-term momentum.

CEO George Chamoun sold 350,000 shares for $7.1M at ACVA on Sep 17-18, reducing stake to 928.2K shares (-27.4%)

CEO Chamoun executed 2 separate sales totaling 350,000 shares for $7,118,363.70 at a blended average price of $20.34. The sales occurred at the stock's 52-week high ($20.67), with the current price matching that peak. In context, the company remains unprofitable (latest quarter net income of $-17,063,000.00) despite 14.2% annual revenue growth, creating a backdrop of operational losses. At the same-ticker level, Chamoun's prior 5 trades at ACVA show mixed timing: his June 2024 sells were followed by positive 90-day returns (+16.7%, +14.9%, +12.6%), while his March 2024 sells saw declines (-7.5%, -5.4%). The current transaction represents a substantial reduction (-27.4% of pre-transaction holdings) at historically favorable valuation, but the insider retains 928.2K shares post-transaction, indicating no complete position exit. The timing at the 52-week high merits observation against forward earnings trajectory given current unprofitability.

CEO Chamoun George sells 350,000 ACVA shares (26.7% of holdings) for $6.2M across three days

CEO Chamoun George executed 3 separate sales totaling 350,000 shares (350.0K shares) for $6,186,666.80 ($6.2M) between June 18–21, 2024, at prices between $17.62 and $17.71, reducing his stake from 1,311,245 shares (1.31M shares) to 961,245 shares (961.2K shares). The transaction occurred while the stock is -3.8% over the past 30 days and -7.4% over the past 90 days; at the current price of $17.74, it sits 7.4% below its 52-week high. His prior 5 trades at ACVA show mixed timing outcomes: 3 of 5 were well-timed at the 90-day mark, with 2023 sales followed by gains but 2024-03 sales all preceded stock declines. Against this backdrop of recent company unprofitability ($-20.5M net income in the latest quarter, though revenue grew 14.2% annually), a CEO selling over one-quarter of his holdings warrants attention to whether this reflects conviction-driven portfolio management or other factors—particularly given the partial nature of the transaction and the FLAG indicating this sale may involve derivative conversion rather than outright liquidation of common shares.